Vasopressin to Treat Hypotension After Pheochromocytoma Resection in an Eleven-Year-Old Boy

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 20, Issue 3, 2006, Pages 394-396

  Deutsch, Eric ^a   Tobias, Joseph D ^a  

^a University of Missouri   (United States)

Author keywords

phenoxybenzamine; pheochromocytomia; vasopressin

Indexed keywords

CISATRACURIUM; FENTANYL; MIDAZOLAM; NORADRENALIN; PHENYLEPHRINE; SEVOFLURANE; THIOPENTAL; VASOPRESSIN;

ANESTHESIA INDUCTION; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; ECHOCARDIOGRAPHY; FLUID RESUSCITATION; HUMAN; HYPERTENSION; HYPOTENSION; INTENSIVE CARE UNIT; MALE; NEUROMUSCULAR BLOCKING; NUCLEAR MAGNETIC RESONANCE IMAGING; PHEOCHROMOCYTOMA; POSTOPERATIVE ANALGESIA; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT OUTCOME;

ADRENAL GLAND NEOPLASMS; CHILD; HUMANS; HYPOTENSION; MALE; PHENOXYBENZAMINE; PHEOCHROMOCYTOMA; VASOPRESSINS;

EID: 33646950419     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jvca.2005.08.014     Document Type: Article

References (22)

1. Burroughs A.K. Pharmacological treatment of acute variceal bleeding. Digestion 59 (1998) 28-36
2. Chugh S.S., Lurie K.G., and Lindner K.H. Pressor with promise. Using vasopressin in cardiopulmonary arrest. Circulation 96 (1997) 2453-2454
3. Overand P.T., and Teply J.F. Vasopressin for the treatment of refractory hypotension after cardiopulmonary bypass. Anesth. Analg 86 (1998) 1207-1209
4. Landry D.W., Levin H.R., Gallant E.M., et al. Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 95 (1997) 1122-1125
5. Morales D., Madigan J., Cullinane S., et al. Reversal by vasopressin of intractable hypotension in the late phase of hemorrhagic shock. Circulation 100 (1999) 226-229
6. The American Heart Association in collaboration with the International Liaison Committee on Resuscitation. Guidelines 2000 for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Part 6: Advanced cardiovascular life support: Section 1: Introduction to ACLS 2000: Overview of recommended changes in ACLS from the guidelines 2000 conference. Circulation 102 suppl 8 (2000) I86-I89
7. Guidelines 2000 for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Part 6: Advanced Cardiovascular Life Support: Section 6: Pharmacology II: Agents to optimize cardiac output and blood pressure. Circulation 102 suppl 8 (2000) I129-I148
8. Roizen M.F., Schrieder B.D., and Hassan S.Z. Anesthesia for patients with pheochromocytoma. Anesthesiol Clin North Am 5 (1987) 269-275
9. Kinney M.A.O., Narr B.J., and Warner M.A. Perioperative management of pheochromocytoma. J Cardiothorac Vasc Anesth 16 (2002) 359-369
10. Hamilton C., Reid J.L., and Sumner D.J. Acute effects of phenoxybenzamine in alpha-adrenoceptor responses in vivo and in vitro. Relation of in vivo pressor responses to the number of specific adrenoceptor binding sites. J Cardiovasc Pharmacol 5 (1983) 863-873
11. Hamilton C., Dalrymple H., and Reid J. Recovery in vivo and in vitro of alpha-adrenergic responses and radioligand binding after phenoxybenzamine. J Cardiovasc Pharmacol 4 suppl 2 (1982) S125-S128
12. Bravo E.L. Pheochromocytoma. Curr Ther Endocinol Metab 6 (1997) 195-197
13. Kinney M.A., Warner M.E., van Heerden J.A., et al. Perianesthetic risks and outcomes of pheochromocytoma and paraganglioma resection. Anesth Analg 91 (2000) 1118-1123
14. Prys-Roberts C. Pheochromocytoma-Recent progress in its management. Br J Anaesth 85 (2000) 44-57
15. Tobias J. Preoperative blood pressure management of children with catecholamine-secreting tumors. Time for a change. Pediatr Anesth 15 (2005) 537-540
16. Motta M., Mossad E., Toscana D., et al. Comparison of phenoxybenzamine to sodium nitroprusside in infants undergoing surgery. J Cardiothorac Vasc Anesth 19 (2005) 54-59
17. Kain Z., Shamberger R.S., and Holzman R.S. Anesthetic management of children with neuroblastoma. J Clin Anesth 5 (1993) 486-491
18. Prys-Roberts C., and Farndon J.R. Efficacy and safety of doxazosin for perioperative management of patients with pheochromocytoma. World J Surg 26 (2002) 1037-1042
19. Day T.A., Randle J.C., and Renaud L.P. Opposing alpha and beta-adrenergic mechanisms mediate dose-dependent actions of norepinephrine on supraoptic vasopressin neurons in vivo. Brain Res 358 (1985) 171-179
20. Tan S.G., Koay C.K., and Chan S.T. The use of vasopressin to treat catecholamine-resistant hypotension after phaeochromocytoma removal. Anaesth Intensive Care 30 (2002) 477-480
21. Augoustides J.G., Abrams M., Berkowitz D., et al. Vasopressin for hemodynamic rescue in catecholamine-resistant vasoplegic shock after resection of massive pheochromocytoma. Anesthesiology 101 (2004) 1022-1024
22. Dyke II P.C., and Tobias J.D. Vasopressin. Applications in clinical practice. J Intensive Care Med 19 (2004) 220-228